Similarly, the senescent TME, enriched in adenosine due to senescent tumor cells stimulating CD73 expression on tumor-associated macrophages via IL-6 and the JAK/STAT3 pathway, impedes anti-tumor immunity [79]. This evidence concerns the gene IL6 and neoplasm.